The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-09
DOI
10.1038/srep12054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis
- (2014) Aiko Nagayama et al. JNCI-Journal of the National Cancer Institute
- Paclitaxel Enhances Antibody-dependent Cell-mediated Cytotoxicity of Trastuzumab by Rapid Recruitment of Natural Killer Cells in HER2-positive Breast Cancer
- (2014) Daishu Miura et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
- (2013) S. Ithimakin et al. CANCER RESEARCH
- Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity
- (2013) Ahmed M. Al-Abd et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells
- (2013) JIN-AH KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Research on drug resistance mechanism of trastuzumab caused by the activation of PI3K/Akt signaling pathway
- (2013) Xi Chen et al. Wspolczesna Onkologia-Contemporary Oncology
- Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells
- (2012) HISANORI MIKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman
- (2012) Neetu Singh et al. PLoS One
- Resveratrol and cellular mechanisms of cancer prevention
- (2011) Yogeshwer Shukla et al. Annals of the New York Academy of Sciences
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent
- (2011) Ali Mokhtar Mahmoud et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling
- (2010) Xin He et al. CANCER LETTERS
- Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo
- (2010) Masayuki Fukui et al. EUROPEAN JOURNAL OF CANCER
- Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation — Rationale, methods and preliminary results from a Sino-American collaboration
- (2010) David M. Eisenberg et al. FITOTERAPIA
- HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
- (2010) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells
- (2010) Qinghe Chen et al. PLoS One
- Breast Cancer, Estrogen Receptor and Ligands
- (2009) Zhenlin Bai et al. ARCHIV DER PHARMAZIE
- Impact of Natural Products on Developing New Anti-Cancer Agents†
- (2009) Gordon M. Cragg et al. CHEMICAL REVIEWS
- Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis
- (2009) T. Ben-Kasus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
- (2008) M. Untch et al. ANNALS OF ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started